2 results
Approved WMOCompleted
The primary objective of this study is to demonstrate the clinical performance of PRO-Kinetic Energy stent in subjects with atherosclerotic disease of native coronary arteries.
Approved WMOCompleted
Primary objectives:* To assess efficacy of nilotinib in pediatric patients with Ph+ CML CPresistant or intolerant to either imatinib or dasatinib.* To assess efficacy of nilotinib in pediatric patients with Ph+ CML APresistant or intolerant to…